Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million contract for bird flu shots that was awarded to Moderna MRNA.O, Bloomberg News reported on Wednesday, citing people familiar with the matter.
The U.S. government had awarded Moderna $590 million in January to advance the development of its bird flu vaccine.
(Reporting by Sneha S K; Editing by Alan Barona)
((Sneha.SK@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.